From: Prognostic models for complete recovery in ischemic stroke: a systematic review and meta-analysis
First author (year) | Setting | Study period | Study design | Model No. | Type of model | Definition of outcome | Participants | No. of complete recovery | Events per variable | Duration of follow-up | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Age | Male | NIHSS score | ||||||||||
Johnston (2000) | America | May 1993 - Dec 1994 | Cohort | 1 | Internal | BI ≥ 95 | 222 | 68.7b | – | 10 (5, 15)a | 125 | 125 | 90 days |
2 | 21 | ||||||||||||
3 | 18 | ||||||||||||
4 | GOS = 1 | 222 | 68.7b | – | 10 (5, 15)a | 108 | 108 | ||||||
5 | 18 | ||||||||||||
6 | 16 | ||||||||||||
Johnston (2003) | America | – | Cohort | 3 | External | BI ≥ 95 | 199 | 67 (59,74)a | 59% | 15(10, 20)a | 78 | 12 | 90 days |
6 | GOS = 1 | 62 | 9 | ||||||||||
Johnston (2002) | America | May 1993 - Dec 1994 | Cohort | 7 | Internal | BI ≥ 95 | 206 | 69 (12)b | – | 10 (5, 16)a | 92 | 92 | 90 days |
8 | 92 | ||||||||||||
9 | 46 | ||||||||||||
10 | GOS = 1 | 206 | 69 (12)b | – | 10 (5, 16)a | 99 | 99 | ||||||
11 | 99 | ||||||||||||
12 | 50 | ||||||||||||
Johnston (2007) | America | – | Cohort | 13 | Development | BI ≥ 95 | 382 | 69 (58, 77)a | 53.9% | 14 (10, 18)a | 123 | 25 | 90 days |
May 2000 & Aug 2005 | External | 266 | 70 (58, 78)a | 53.0% | 5 (3, 10)a | 167 | 34 | ||||||
– | 14 | Development | 382 | 69 (58, 77)a | 53.9% | 14 (10, 18)a | 123 | 16 | |||||
May 2000 & Aug 2005 | External | 266 | 70 (58, 78)a | 53.0% | 5 (3, 10)a | 167 | 21 | ||||||
– | 15 | Development | mRS ≤ 1 | 382 | 69 (58, 77)a | 53.9% | 14 (10, 18)a | 75 | 15 | ||||
May 2000 & Aug 2005 | External | 266 | 70 (58, 78)a | 53.0% | 5 (3, 10)a | 148 | 30 | ||||||
– | 16 | Development | 382 | 69(58, 77)a | 53.9% | 14 (10, 18)a | 75 | 10 | |||||
May 2000 & Aug 2005 |  | 16 | External | mRS ≤ 1 | 266 | 70 (58, 78)a | 53.0% | 5 (3, 10)a | 148 | 19 | 90 days | ||
Weimar (2002) | Germany | 1998 - 1999 | Cohort | 17 | Development | BI ≥ 95 | 1743 | 68.1 (12.7)b | 59.2% | 6.9 (6.2)b | 1021 | 102 | 100 days |
German Stroke Study Collaboration (2004) | Germany | Feb 2001 - Mar 2002 | Cohort | External | BI ≥ 95 | 1470 | 67.9 (12.4)b | 57.3% | 6.4 (6.0)b | 831 | 76 | 100 days | |
Weimar (2004) | Germany | – | Cohort | 18 | Development | BI ≥ 95 | 1079 | 67.0 (12.3)b | 60.5% | – | 644 | 322 | 100 days |
Feb 2001 - Mar 2002 | Cohort | External | BI ≥ 95 | 1307 | 68.2 (12.5)b | 56.5% | 7.6 (6.9)b | 722 | 361 | 100 days | |||
Konig (2008) | – | – | Cohort | External | BI ≥ 95 | 4441 | 68.8 (12.3)b | 55.8% | 13.4 (6.5)b | 1970 | 985 | 90 days | |
Schiemanck (2006) | Netherland | 1999 - 2001 | Cohort | 19 | Development | BI ≥ 19 | 75 | 63 (15)b | 47% | 11 (6)b | 33 | 17 | 365 days |
20 | 7 | ||||||||||||
Patti (2016) | America | 2013 - 2014 | Cohort | 21 | Development | mRS ≤ 1 | 414 | 70 (50, 69)a | 50% | 5 (2, 13)a | 230 | 77 | 90 days |
22 | 204 | – | – | – | – | – | |||||||
23 | 210 | – | – | – | – | – |